Preclinical CROs in Asia Pacific

46 contract research organizations in our directory list a site in Asia Pacific, across 6 countries. 29 report GLP capability and 10 report AAALAC accreditation. Compare services, species and accreditations below, and contact labs directly from their profiles.

46 CROs 29 GLP 10 AAALAC 6 countries

Preclinical research in Asia Pacific

Asia Pacific has become a major source of preclinical capacity. China and India host large integrated discovery and toxicology providers, Japan and South Korea have established GLP labs serving domestic and global sponsors, and Australia is often used for early clinical work that follows preclinical studies.

Regulatory status differs across the region: Japan, South Korea, Australia, New Zealand, India and Singapore adhere to the OECD Mutual Acceptance of Data system, while China does not fully adhere. Check inspection history and data acceptance for the regulator you plan to file with.

Among the CROs listed in Asia Pacific, the most common services are In Vivo Efficacy, GLP Toxicology, Toxicology and Pharmacokinetics. The species they most often work with are Mouse, Rat and Dog.

Preclinical CROs in Asia Pacific

Showing 46 CROs with a site in Asia Pacific. Order rotates daily so no lab is permanently listed first.

PharmaLegacy Laboratories

Shanghai GLP AAALAC

Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.

Bone & Joint Models In Vivo Efficacy Inflammation Models Metabolic Disease Models Oncology Models Dog Mouse Non-human Primate Rabbit

Nihon Bioresearch

Hashima GLP

Japanese preclinical CRO offering GLP safety and efficacy studies for drugs, devices and regenerative products, with long minipig experience.

GLP Toxicology In Vivo Efficacy Infectious Disease Models Medical Device Testing Safety Pharmacology Minipig Mouse Rabbit Rat

Biocytogen

Beijing

Beijing-based company providing genetically engineered and humanized mouse models with in vivo pharmacology services, especially for oncology and immunology antibody programs.

Antibody Programs In Vivo Efficacy Oncology Models Syngeneic Models Xenograft Models Mouse

Korea Institute of Toxicology (KIT)

Daejeon GLP

Government-funded Korean research institute providing GLP nonclinical safety studies, including inhalation toxicology, safety pharmacology and reproductive toxicity.

GLP Toxicology Inhalation Toxicity Repeat-Dose Toxicity Reproductive Toxicity Safety Pharmacology Dog Mouse Non-human Primate Rat

Eurofins Advinus

Bengaluru GLP

Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.

Genetic Toxicology GLP Toxicology Pharmacokinetics Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Rabbit Rat

K-Prime Research (BTT Group)

Osong GLP

Korean nonhuman primate CRO in the Biotoxtech group with GLP repeat-dose toxicity and cardiovascular safety pharmacology in NHPs, plus NHP inhalation studies.

Cardiovascular Safety GLP Toxicology Inhalation Toxicity Repeat-Dose Toxicity Safety Pharmacology Cynomolgus monkey Non-human Primate

TheraIndx Lifesciences

Bengaluru

Bengaluru preclinical CRO providing pharmacology, pharmacokinetic and toxicology studies.

In Vivo Efficacy Pharmacokinetics Toxicology Mouse Rat

vivoPharm

Bundoora GLP

Preclinical oncology and immuno-oncology CRO with orthotopic and metastatic models, whole-body imaging and GLP toxicology, with sites in Australia and the US.

Bioanalysis In Vivo Efficacy In Vivo Imaging Oncology Models Toxicology Mouse Rat

Laxai Life Sciences

Hyderabad

Hyderabad discovery services company offering biology and DMPK support alongside chemistry.

In Vitro ADME In Vivo Efficacy In Vivo PK Mouse Rat

CorestemChemon (ChemOn)

Yongin GLP AAALAC

South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.

GLP Toxicology In Vivo Efficacy Pharmacokinetics Repeat-Dose Toxicity Safety Pharmacology Dog Mouse Rabbit Rat

BoZo Research Center

Tokyo GLP

Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.

Carcinogenicity Studies Genetic Toxicology GLP Toxicology Pharmacokinetics Minipig Mouse Rat

DT&CRO

Yongin GLP

Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.

Bioanalysis GLP Toxicology In Vivo Efficacy Medical Device Testing Pharmacokinetics Dog Mouse Rabbit Rat

Medicilon

Shanghai GLP AAALAC
Bioanalysis Toxicology Dog Mouse Non-human Primate Rabbit

Jai Research Foundation (JRF)

Vapi GLP

Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.

Genetic Toxicology GLP Toxicology Repeat-Dose Toxicity Reproductive Toxicity Toxicology Dog Mouse Rabbit Rat

Biotoxtech

Cheongju GLP AAALAC

Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.

Carcinogenicity Studies Genetic Toxicology GLP Toxicology Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Non-human Primate Rabbit

Palamur Biosciences

Mahabubnagar GLP

Indian GLP-certified preclinical CRO providing toxicology and safety studies.

GLP Toxicology Pharmacokinetics Toxicology Dog Mouse Rabbit Rat

JOINN Laboratories

Beijing GLP

Large China-based nonclinical CRO offering GLP safety assessment, pharmacology, pharmacokinetics and bioanalysis, with operations in China and the United States.

Bioanalysis GLP Toxicology In Vivo Efficacy Pharmacokinetics Repeat-Dose Toxicity Cynomolgus monkey Dog Non-human Primate Rat

HLB bioStep (formerly Knotus)

Incheon GLP

Korean non-clinical CRO focused on efficacy testing of new drug candidates, with research facilities in Songdo, Incheon.

In Vivo Efficacy Inflammation Models Toxicology Mouse Rat

Aragen Life Sciences

Hyderabad GLP

Integrated discovery and development services company in India offering in vivo pharmacology, DMPK, bioanalysis and safety assessment alongside chemistry and biologics services.

Bioanalysis In Vitro ADME In Vivo Efficacy In Vivo PK Toxicology Dog Mouse Rat

Hubei Topgene Biotechnology

Wuhan GLP

Wuhan CRO integrating NHP breeding with toxicity and safety evaluation, PK/PD, molecular imaging and bioanalysis.

Bioanalysis In Vivo Imaging Pharmacokinetics Toxicology Non-human Primate

Agilex Biolabs

Adelaide GLP

Australian bioanalytical and toxicology CRO with OECD GLP labs, supporting nonclinical toxicology and clinical bioanalysis.

Bioanalysis GLP Toxicology Immunogenicity Testing Toxicokinetics Mouse Rat

Hamamatsu Pharma Research

Hamamatsu AAALAC

AAALAC-accredited Japanese CRO specializing in nonhuman primate disease models for preclinical efficacy and proof of concept.

CNS Disease Models In Vivo Efficacy Metabolic Disease Models Non-human Primate

SAFE Pharma (Beijing Saifu)

Beijing GLP

Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.

Gene Therapy Studies GLP Toxicology Pharmacokinetics Safety Pharmacology Dog Non-human Primate Rat

Jubilant Biosys

Bengaluru

Indian integrated drug discovery CRO offering in vivo pharmacology and DMPK alongside chemistry and biology.

In Vitro ADME In Vivo Efficacy In Vivo PK Oncology Models Mouse Rat

PhoenixBio

Higashihiroshima

Japanese company offering humanized-liver mice and contract studies for human metabolism, DMPK and hepatitis research.

Hepatic Disease Models In Vivo PK Infectious Disease Models Metabolite Identification Mouse

InnoStar

Shanghai GLP AAALAC

Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.

Bioanalysis Biomarker Analysis Cell Therapy Gene Therapy Studies GLP Toxicology Dog Mouse Non-human Primate Rat

WuXi AppTec

CN Verified GLP AAALAC

Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.

Bioanalysis Histology Pharmacokinetics Surgery Toxicology Cynomolgus monkey Dog Mouse Pig

Bioneeds

Bengaluru GLP AAALAC

OECD GLP-certified preclinical CRO near Bengaluru providing regulatory toxicology for pharmaceuticals, biologics, devices and chemicals.

Genetic Toxicology GLP Toxicology Immunogenicity Testing Medical Device Testing Toxicology Guinea Pig Mouse Rabbit Rat

Anthem Biosciences

Bengaluru GLP

Bengaluru CRDMO offering discovery services including DMPK, safety and bioanalysis alongside development and manufacturing.

Bioanalysis In Vitro ADME In Vivo PK Toxicology Mouse Rat

Shanghai Model Organisms Center (SMOC)

Shanghai

Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.

In Vivo Efficacy Metabolic Disease Models Oncology Models Mouse Rat

Shanghai LIDE Biotech

Shanghai

Shanghai oncology CRO with patient-derived xenograft and other tumor models for efficacy studies.

In Vivo Efficacy Oncology Models PDX Models Mouse

GemPharmatech

Nanjing

Chinese provider of genetically engineered mouse models with in vivo pharmacology services across oncology, immunology and metabolic disease.

In Vivo Efficacy Metabolic Disease Models Oncology Models PDX Models Mouse

Kunming Biomed International (KBI)

Kunming AAALAC

Southwest China pharmacology CRO specializing in nonhuman primate efficacy, PK/PD and exploratory safety studies.

In Vivo Efficacy Pharmacokinetics Toxicology Non-human Primate

SMC Laboratories

Tokyo

Tokyo CRO known for NASH/MASH and fibrosis mouse models, with efficacy studies across liver, kidney and metabolic disease.

Hepatic Disease Models In Vivo Efficacy Metabolic Disease Models Renal Disease Models Mouse

Prisys Biotechnologies

Shanghai GLP

Shanghai CRO centered on nonhuman primate efficacy and safety studies, with NHP disease models across metabolism, cardiovascular, renal, neurology and ophthalmology, clinical-style imaging and interventional surgery.

In Vivo Efficacy In Vivo Imaging MRI Studies PET Imaging Surgical Models Cynomolgus monkey Non-human Primate

Shin Nippon Biomedical Laboratories (SNBL)

Kagoshima GLP

Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.

GLP Toxicology Pharmacokinetics Repeat-Dose Toxicity Reproductive Toxicity Safety Pharmacology Cynomolgus monkey Dog Non-human Primate Rat

Vivo Bio Tech

Hyderabad GLP

Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.

GLP Toxicology In Vivo Efficacy Pharmacokinetics Toxicology Dog Mouse Non-human Primate Rabbit

Keyfronbio (BTT Group)

KR GLP

Korean nonclinical pharmacology CRO in the Biotoxtech group offering efficacy studies, PCR-based biodistribution for cell and gene therapies, and GLP bioanalysis.

Bioanalysis Biodistribution Gene Therapy Studies In Vivo Efficacy Mouse Rat

QuBEST Bio

KR

Korean nonclinical CRO providing early PK, TK and bioanalytical method development and sample analysis.

Bioanalysis In Vivo PK Method Development Toxicokinetics Mouse Rat

Sai Life Sciences

Hyderabad

Integrated CRO-CDMO in India whose discovery biology group provides in vivo pharmacology, DMPK and bioanalysis for small molecule programs.

Bioanalysis In Vitro ADME In Vivo Efficacy In Vivo PK Mouse Rat

Questions to ask a CRO in Asia Pacific

  • Will the study run at the site in Asia Pacific, or could work be moved to another of your facilities?
  • How do you receive test article shipments, and what import permits or customs paperwork do you handle?
  • Can our team visit the facility before the study starts and during critical phases?
  • Which regulators and GLP monitoring authorities have inspected this site, and when?
  • What is your current lead time for our species at this site?

For a full checklist, see our CRO selection guide.